The effect of carbamazepine on the steady‐state pharmacokinetics of ziprasidone in healthy volunteers

Abstract

Induction of CYP3A4 with carbamazepine led to a modest reduction (<36%) in steady-state exposure to ziprasidone that is believed to be clinically insignificant.